Today: 3 April 2026

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Range Resources slides as gas prices sink after EIA storage data — what traders watch next

Range Resources slides as gas prices sink after EIA storage data — what traders watch next

Range Resources shares fell 3% to $34.99 after U.S. natural gas futures dropped 6% following a government storage report. The EIA said utilities withdrew 38 billion cubic feet of gas last week, leaving inventories 2% below last year but 2% above the five-year average. EQT, Antero Resources, and CNX Resources also traded lower.
Lionsgate Studios stock today: LION slides after insider sale filings hit the tape

Lionsgate Studios stock today: LION slides after insider sale filings hit the tape

Lionsgate Studios shares dropped 3.4% to $8.94 midday after SEC filings showed CEO Jon Feltheimer and Vice Chair Michael Burns sold stock in late December for tax planning. Feltheimer sold 195,000 shares at $8.28, Burns sold 21,748 at $9.01. The stock traded between $8.94 and $9.16 on volume of 1.23 million shares. Investors are watching if shares hold below $9 ahead of the next earnings update.
AAON stock slips even after credit line boost to $600 million — what Wall Street is watching next

AAON stock slips even after credit line boost to $600 million — what Wall Street is watching next

AAON shares dropped 2.7% to $76.48 by midday after the company expanded its revolving credit facility by $100 million, raising total borrowing capacity to $600 million. The move followed use of an “accordion” feature, with other loan terms unchanged. Investors reacted cautiously amid thin year-end trading. The credit line is led by Bank of Oklahoma, Wells Fargo, Bank of America, U.S. Bank, and Associated Bank.
31 December 2025
Genmab stock slides today as GMAB shelves acasunlimab; Merus takeout steps in focus

Genmab stock slides today as GMAB shelves acasunlimab; Merus takeout steps in focus

Genmab A/S shares fell 3.3% to $30.44 in New York after the company dropped further development of acasunlimab, a late-stage cancer drug, following a portfolio review. Genmab said the move does not affect its 2025 guidance and will focus on other pipeline drugs. The company also completed its acquisition of Merus N.V., paying $97 per share in a tender offer. Merus requested Nasdaq delist its stock after the merger.
Abivax stock drops today as ABVX traders trim Eli Lilly takeover bets into year-end

Abivax stock drops today as ABVX traders trim Eli Lilly takeover bets into year-end

Abivax’s U.S.-listed shares fell 3.8% to $133.04 late Wednesday morning, reversing part of a recent surge driven by takeover speculation and index inclusion. Trading volume reached about 348,000 shares as the stock swung between $132.13 and $140.25. Investors await updates on strategic interest and new data for obefazimod, the company’s lead drug candidate.
Nasdaq Keeps PLTS Trading Halted With No Reason Listed as Bengaluru ‘My Room, My Rules’ Row Spreads Online

Nasdaq Keeps PLTS Trading Halted With No Reason Listed as Bengaluru ‘My Room, My Rules’ Row Spreads Online

Nasdaq kept trading in Platinum Analytics Cayman Limited (PLTS) halted Wednesday, listing the reason as “not available” as of 10:23 a.m. ET. The exchange had previously halted PLTS in October after an SEC suspension and requested more information from the company. No further details were provided in the latest notice. Separately, a Bengaluru renter’s late-night noise complaint on Reddit sparked debate over shared-living boundaries.
31 December 2025
Why Life360 stock is sliding today as year-end trading hits tech names

Why Life360 stock is sliding today as year-end trading hits tech names

Life360 shares fell 4.4% to $63.79 in morning Nasdaq trading, down $2.94 from Tuesday’s close, with about 108,000 shares changing hands. The drop came as tech stocks extended losses on the final trading day of 2025. Life360 recently raised its full-year revenue outlook and agreed to buy ad-tech firm Nativo for $120 million. The company’s next earnings report is set for Feb. 26.
XPeng stock slides 6% today as Chinese EV shares retreat in thin year-end trade

XPeng stock slides 6% today as Chinese EV shares retreat in thin year-end trade

XPeng’s U.S.-listed shares fell 6% to $19.99 by late morning in New York on Wednesday, while NIO dropped 9.5% and Li Auto slid 4.8%. Traders cited thin year-end liquidity and awaited January delivery data and details on China’s updated EV subsidies. XPeng’s ADRs traded between $19.87 and $20.54, with volume near 3.9 million shares. Broader U.S. stocks also slipped ahead of the New Year’s holiday.
1 331 332 333 334 335 584

Stock Market Today

  • Aisin (TSE:7259) Seen Undervalued Amid Recent Share Price Decline
    April 3, 2026, 12:13 PM EDT. Aisin's shares have fallen about 8% in the last month and 23% over three months, signaling short-term weakness despite a 58% total return over the past year. Currently trading at ¥2,245.5, the stock's price-to-earnings (P/E) ratio stands at 9.8x, below peers' average of 17.4x and the auto components industry average of 10x, suggesting potential undervaluation. Analysts note the stock trades under an estimated fair P/E of 14.6x. However, the market may be pricing in future growth risks given a 54% intrinsic discount. A discounted cash flow (DCF) model values the stock at ¥4,894.59, more than double the current price, raising questions about long-term market expectations for Aisin, an auto parts leader.
Go toTop